This week includes a test of treatment options, a case report of intolerable nausea, and our new series on difficult-to-treat depression.

New research explores how psilocybin therapy and escitalopram alter brain dynamics in different ways to treat depression.

Esmethadone showed mixed results in phase 3 trials with promising response and remission rates, especially in severe cases.

Stanford research shows that advanced brain imaging and AI can identify depression biotypes, enabling more effective treatment options.

Ilse Wiechers presents an in-depth exploration of advanced neuromodulation techniques for treating difficult-to-treat depression. Discover cutting-edge research, clinical applications, and the latest insights on personalized brain stimulation approaches aimed...

Dr. Lisa M. Harding discusses the latest advancements in neuroimaging and personalized treatment strategies for difficult-to-treat depression. Learn about cutting-edge research, diagnostic tools, and targeted therapies that are paving...